PHAR

Pharming Group N.V. - ADS, each representing 10 ordinary shares (PHAR)

About Pharming Group N.V. - ADS, each representing 10 ordinary shares (PHAR)

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Details

Daily high

$12.72

Daily low

$12.13

Price at open

$12.40

52 Week High

$21.34

52 Week Low

$9.11

Market cap

881.9M

Dividend yield

Volume

12,582

Avg. volume

16,490

P/E ratio

36.69

Pharming Group N.V. - ADS, each representing 10 ordinary shares News